BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4540495)

  • 41. Treatment of metronidazole-resistant Trichomonas vaginalis.
    Goldman LM; Upcroft JA; Workowski K; Rapkin A
    Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A strain of Trichomonas vaginalis with reduced sensitivity for metronidazole].
    Dijkmans BA; Polderman AM; Heintz AP; van Furth R
    Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2193-5. PubMed ID: 6983659
    [No Abstract]   [Full Text] [Related]  

  • 43. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
    Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
    Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.
    Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE
    J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Disparaged leukorrhea and resistant forms of Trichomonas vaginalis].
    Hainaux H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):367-9. PubMed ID: 4549774
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of tinidazole on T. vaginalis in vitro].
    Savoia D; Martinetto P; Pugliese A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of vaginal trichomoniasis with a new anti-protozoal compound ( -chloromethyl-2-methyl-5-nitro-1-imidazole-ethanol).
    Lean TH; Vengadasalam D
    Br J Vener Dis; 1973 Feb; 49(1):69-71. PubMed ID: 4348437
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro susceptibility of Trichomonas vaginalis strains to metronidazole--a Nigerian experience.
    Ikeh EI; Bello CS; Ajayi JA
    Genitourin Med; 1993 Jun; 69(3):241-2. PubMed ID: 8335321
    [No Abstract]   [Full Text] [Related]  

  • 51. Activities of dicationic compounds against Trichomonas vaginalis.
    Crowell AL; Stephens CE; Kumar A; Boykin DW; Secor WE
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3602-5. PubMed ID: 15328138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
    Wright JM; Dunn LA; Kazimierczuk Z; Burgess AG; Krauer KG; Upcroft P; Upcroft JA
    Parasitol Res; 2010 Sep; 107(4):847-53. PubMed ID: 20532912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapeutic nitroheterocycles. 7. Substituted 5-alkylthiomethyl-3-(5-nitro-2-imidazolyl)methyleneamino-2-oxazolidinones.
    Rufer C; Kessler HJ; Schröder E
    J Med Chem; 1971 Oct; 14(10):934-5. PubMed ID: 5315670
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metronidazole resistant Trichomonas vaginalis in Brisbane.
    Voolmann T; Boreham P
    Med J Aust; 1993 Oct; 159(7):490. PubMed ID: 8412928
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro activity of a new nitroimidazole derivative (CP 12 574) on 67 strains of T. vaginalis.
    Miltgen F; Dellenbach P; Kremer M
    Wiad Parazytol; 1973; 19(3):499-501. PubMed ID: 4542510
    [No Abstract]   [Full Text] [Related]  

  • 58. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
    Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
    Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sensitivity of Trichomonas to flagyl and its importance in the treatment of Trichomonas infection in women].
    Starostina ZD
    Vestn Dermatol Venerol; 1973 Oct; 47(10):84-5. PubMed ID: 4544528
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of trichomoniasis vaginalis with imidazole derivatives. Comparative study of other trichomonicides].
    KASKARELES D; DANEZES I
    Hell Iatr; 1963 May; 32():523-8. PubMed ID: 13962688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.